<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36495266</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Exosomal TAR DNA binding protein 43 profile in canine model of amyotrophic lateral sclerosis: a preliminary study in developing blood-based biomarker for neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>34</StartPage><EndPage>41</EndPage><MedlinePgn>34-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2153162</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Blood-based biomarkers provide a crucial information in the progress of neurodegenerative diseases with a minimally invasive sampling method. Validated blood-based biomarker application in people with amyotrophic lateral sclerosis would derive numerous benefits. Canine degenerative myelopathy is a naturally occurring animal disease model to study the biology of human amyotrophic lateral sclerosis. Serum derived exosomes are potential carriers for cell-specific cargoes making them ideal venue to study biomarkers for a variety of diseases and biological processes. This study assessed the exosomal proteins that may be assigned as surrogate biomarker that may reflect biochemical changes in the central nervous system.</AbstractText><AbstractText Label="METHODS">Exosomes were isolated from canine serum using commercial exosome isolation reagents. Exosomes target proteins contents were analyzed by the Western blotting method.</AbstractText><AbstractText Label="RESULTS">The profiles of potential biomarker candidates in spinal cord homogenate and that of serum-derived exosomes were found elevated in dogs with degenerative myelopathy as compared to control subjects.</AbstractText><AbstractText Label="CONCLUSIONS">Serum-derived exosomal biomolecules can serve as surrogate biomarkers in neurodegenerative diseases.KEY MESSAGESA canine with degenerative myelopathy can serve as a model animal to study human amyotrophic lateral sclerosis.Serum-derived exosomes contain Transactive Response DNA Binding Protein 43 (TDP-43), a potential biomarker candidate.The levels of spinal cord TDP-43 proteins and that of serum-derived exosomes exhibited similar profiling. Therefore, serum derived exosomes may be used as a venue for establishing blood-based biomarkers for neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfeiffer</LastName><ForeName>Penelope</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coates</LastName><ForeName>Joan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>University of Missouri-Columbia, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esqueda</LastName><ForeName>Yajaira M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Getchell</LastName><ForeName>Kyleigh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLenon</LastName><ForeName>Myra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosa</LastName><ForeName>Edina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agbas</LastName><ForeName>Abdulbaki</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3854-7784</Identifier><AffiliationInfo><Affiliation>Kansas City University, Kansas City, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heartland Center for Mitochondrial Medicine, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">degenerative myelopathy</Keyword><Keyword MajorTopicYN="N">exosome</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>10</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36495266</ArticleId><ArticleId IdType="pmc">PMC9746620</ArticleId><ArticleId IdType="doi">10.1080/07853890.2022.2153162</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beyer L, Gunther R, Koch JC, et al. . TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2021;8(1):271&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818221</ArticleId><ArticleId IdType="pubmed">33263951</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder V, Gregory JM, Barria MA, et al. . TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18(1):90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027783</ArticleId><ArticleId IdType="pubmed">29954341</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, et al. . Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139(Pt 12):3187&#x2013;3201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T, Yamashita T, Tamaoka A, et al. . Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. Int J Mol Sci. 2019;20(13):3148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6651127</ArticleId><ArticleId IdType="pubmed">31252669</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC.. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15(1):45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegtel DM, Gould SJ.. Exosomes. Annu Rev Biochem. 2019;88:487&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">31220978</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint-Pol J, Gosselet F, Duban-Deweer S, et al. . Targeting and crossing the blood&#x2013;brain barrier with extracellular vesicles. Cells. 2020;9(4):851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7226770</ArticleId><ArticleId IdType="pubmed">32244730</ArticleId></ArticleIdList></Reference><Reference><Citation>Morad G, Carman CV, Hagedorn EJ, et al. . Tumor-derived extracellular vesicles breach the intact blood&#x2013;brain barrier via transcytosis. ACS Nano. 2019;13(12):13853&#x2013;13865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169949</ArticleId><ArticleId IdType="pubmed">31479239</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu M, Lin Q, Huang L, et al. . Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson&#x2019;s disease. J Control Release. 2018;287:156&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165139</ArticleId></ArticleIdList></Reference><Reference><Citation>What is ALS? The ALS Association ; 2014.  [updated 2014 Feb 16]. Available from: www.alsa.org</Citation></Reference><Reference><Citation>Wijesekera LC, Leigh PN.. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Brockington A, Scaber J, et al. . Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler. 2010;11(4):369&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182546</ArticleId><ArticleId IdType="pubmed">20001488</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P.. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918&#x2013;1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Amyotrophic lateral sclerosis. Medscape; 2014. Available from: http://emedicine.medscape.com/article/1170097-overview</Citation></Reference><Reference><Citation>Wegorzewska I, Baloh RH.. TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegener Dis. 2011;8(4):262&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214943</ArticleId><ArticleId IdType="pubmed">21124004</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T, Johnson GS, Wade CM, et al. . Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2009;106(8):2794&#x2013;2799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder AL, Price JA, Adams JP, et al. . A retrospective study of the prevalence of the canine degenerative myelopathy associated superoxide dismutase 1 mutation (SOD1:c.118G&#x2009;&gt;&#x2009;A) in a referral population of German Shepherd dogs from the UK. Canine Genet Epidemiol. 2014;1:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579386</ArticleId><ArticleId IdType="pubmed">26401327</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan BR, Coates JR, Johnson GC, et al. . Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis. J Neurosci Res. 2013;91(12):1639&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096151</ArticleId><ArticleId IdType="pubmed">24043596</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan BR, Coates JR, Johnson GC, et al. . Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis. J Neurosci Res. 2014;92(4):531&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096142</ArticleId><ArticleId IdType="pubmed">24375814</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates JR, Wininger FA.. Canine degenerative myelopathy. Vet Clin North Am Small Anim Pract. 2010;40(5):929&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">20732599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, et al. . Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72(22):1948&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">19487653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage J, Hall L, McVey A, et al. . Use of capillary electrophoresis immunoassay to search for potential biomarkers of amyotrophic lateral sclerosis in human platelets. J Vis Exp. 2020;156(e60638):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32090995</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, et al. . Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh RH. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J. 2011;278(19):3539&#x2013;3549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177991</ArticleId><ArticleId IdType="pubmed">21777387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M, Lee S, Jeon YM, et al. . The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med. 2020;52(10):1652&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>miRCURY Exosome kits handbook. Qiagen; 2017. p. 7&#x2013;8. HB-2434-001_1107923_HB_miRCURY_Exo_Isolation_Kits_1217%20(3).pdf</Citation></Reference><Reference><Citation>Feneberg E, Charles PD, Finelli MJ, et al. . Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP. Brain Pathol. 2021;(4):e12923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412074</ArticleId><ArticleId IdType="pubmed">33300249</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz ML, Jensen CA, Student JT, et al. . Cervical spinal cord and motor unit pathology in a canine model of SOD1-associated amyotrophic lateral sclerosis. J Neurol Sci. 2017;378:193&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">28566164</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Carrero JJ, Zagai U, et al. . Blood biomarkers and prognosis of amyotrophic lateral sclerosis. Eur J Neurol. 2020;27(11):2125&#x2013;2133.</Citation><ArticleIdList><ArticleId IdType="pubmed">32557963</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D, Ulusu NN.. Importance of the serum biochemical parameters as potential biomarkers for rapid diagnosis and evaluating preclinical stage of ALS. Med Hypotheses. 2020;141:109736.</Citation><ArticleIdList><ArticleId IdType="pubmed">32315925</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodovitch A, Boucraut J, Delmont E, et al. . Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS. Sci Rep. 2021;11(1):703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803734</ArticleId><ArticleId IdType="pubmed">33436881</ArticleId></ArticleIdList></Reference><Reference><Citation>Averill DR Jr. Degenerative myelopathy in the aging German Shepherd dog: clinical and pathologic findings. J Am Vet Med Assoc. 1973;162(12):1045&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">4196853</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng R, Coates JR, Johnson GC, et al. . Breed distribution of SOD1 alleles previously associated with canine degenerative myelopathy. J Vet Intern Med. 2014;28(2):515&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4238831</ArticleId><ArticleId IdType="pubmed">24524809</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Chakrabartty A.. Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762(11&#x2013;12):1025&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">16814528</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, et al. . Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLOS One. 2010;5(7):e11552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, et al. . Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13(11):1396&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, Shibuya K, Sato Y, et al. . Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler. 2011;12(2):140&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">21126161</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Truax AC, et al. . TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol. 2007;66(3):177&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Thery C, Witwer KW, Aikawa E, et al. . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Xu Y, Deng W, et al. . Brain derived exosomes are a double-edged sword in Alzheimer&#x2019;s disease. Front Mol Neurosci. 2020;13:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274346</ArticleId><ArticleId IdType="pubmed">32547364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Beck MV, Griffith JD, et al. . Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2018;115(18):4661&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor EA, Fee L, Tao Y, et al. . Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2016;113(3):614&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725519</ArticleId><ArticleId IdType="pubmed">26719414</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi S, Israel S, Nagy C, et al. . The emerging role of exosomes in mental disorders. Transl Psychiatry. 2019;9(1):122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6438960</ArticleId><ArticleId IdType="pubmed">30923321</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks WA, Sharma P, Bullock KM, et al. . Transport of extracellular vesicles across the blood&#x2013;brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. 2020;21(12):4407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352415</ArticleId><ArticleId IdType="pubmed">32575812</ArticleId></ArticleIdList></Reference><Reference><Citation>Malm T, Loppi S, Kanninen KM.. Exosomes in Alzheimer&#x2019;s disease. Neurochem Int. 2016;97:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">27131734</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya R, Zingg W, Shetty S, et al. . Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J Control Release. 2020;323:225&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299747</ArticleId><ArticleId IdType="pubmed">32289328</ArticleId></ArticleIdList></Reference><Reference><Citation>Long X, Yao X, Jiang Q, et al. . Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury. J Neuroinflammation. 2020;17(1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7082961</ArticleId><ArticleId IdType="pubmed">32192523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>